Natera to Host Special Investor Call in Response to Misleading Short Seller Report

Rhea-AI Summary

Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA testing, has announced an investor call on March 10, 2022, to address a recent misleading report by short sellers. CFO Mike Brophy will provide updates and clarify the misinformation. The call will be held at 4:00 a.m. PT (7:00 a.m. ET), with a live dial-in option available for participants. A replay of the webcast will be accessible post-event on Natera's investor relations site. Natera emphasizes its commitment to providing accurate genetic testing validated by extensive peer-reviewed research.

AUSTIN, Texas, March 9, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that Mike Brophy, chief financial officer, will provide an update on a recent misleading short seller report in a special investor call.

Conference Call Information:

Date:	March 10, 2022
Time:	4:00 a.m. PT (7:00 a.m. ET)
Live Dial-In:	(877) 823-0171, Domestic
	(617) 500-6932, International
Password:	9967134
Webcast:	https://edge.media-server.com/mmc/p/bgatjhxh

A webcast replay will be available at investor.natera.com.

About Natera

Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier, more targeted interventions that help lead to longer, healthier lives. Natera's tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.

Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Kate Stabrawa, Communications, Natera, Inc., 720-318-4080 pr@natera.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/natera-to-host-special-investor-call-in-response-to-misleading-short-seller-report-301499596.html

SOURCE Natera, Inc.

FAQ

What is Natera's response to the short seller report?

Natera will hold a special investor call on March 10, 2022, led by CFO Mike Brophy, to address the misleading report by short sellers.

When is the Natera investor call scheduled?

The investor call is scheduled for March 10, 2022, at 4:00 a.m. PT (7:00 a.m. ET).

How can investors join the Natera investor call?

Investors can join the call by dialing (877) 823-0171 domestically or (617) 500-6932 internationally.

Will there be a replay of the Natera investor call?

Yes, a replay of the webcast will be available on Natera's investor relations website after the call.

What does Natera specialize in?

Natera specializes in cell-free DNA testing for oncology, women's health, and organ health.